Seasoned biopharma executive brings more than 25 years of business development and strategic partnership experience to ...
Volatility and private equity cash needs, not a market bet, may explain the endowment’s crypto shift, experts say.
Alumni interviewers said Harvard College’s policy barring them from mentioning applicants’ race or national origin in their ...
LUND, SE / ACCESS Newswire / March 2, 2026 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today comments on the announcement by Shanghai Henlius Biotech, Inc. that the first patient has been dosed in ...
Some of Epstein’s ties to the school were hiding in plain sight, yet Harvard officials missed or looked past them during ...
StockStory.org on MSN
The 5 most interesting analyst questions from Avantor’s Q4 earnings call
Avantor’s fourth quarter was marked by a negative market reaction, as investors responded to a 1.4% year-over-year revenue decline and operating margin compression. Management attributed these results ...
Twist Bioscience's stock has moved high in recent months, driven by optimism related to AI-enabled drug discovery and MRD testing. Q1 growth was modest, due in large part to an air pocket in demand ...
Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and ...
SOUTH SAN FRANCISCO, Calif., February 10, 2026--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library ...
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation misses on earnings expectations. Reported EPS is $-0.49946 EPS, expectations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results